An interventional study of Pulsed Ultrasound Therapy in Entrapment Neuropathies, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to participants aged 18 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-06.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
The current study investigates the effect of different doses of pulses ultrasound therapy on different nerve conduction parameters of the median nerve in healthy volunteering subjects.
In the current study, we apply pulsed ultrasound therapy on median nerves of healthy volunteer subjects, at 1 W/cm2 10% duty cycle, 3 W/cm2 10% duty cycle, 1 W/cm2 50% duty cycle, and 3 w/cm2 50% duty cycle. Parameters of median nerve conduction study, Latency, amplitude, area, duration and forearm NCV are recorded before and after application of ultrasound therapy.
105 studies on the registry are indexed under Nerve Compression Syndromes; 13 are open to participants now.
This study's planned enrollment of 120 is above the median of 52 across 66 interventional studies indexed under Nerve Compression Syndromes.
Browse Nerve Compression Syndromes studies →Cairo University is the lead sponsor of 4,909 studies on the registry; 1,445 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Pulsed US, 1 W/cm2, 10% duty cycle.
Device: Pulsed Ultrasound Therapy
Pulsed US, 1 W/cm2, 50% duty cycle.
Device: Pulsed Ultrasound Therapy
Pulsed US, 3 W/cm2, 10% duty cycle.
Device: Pulsed Ultrasound Therapy
Pulsed US, 3 W/cm2, 50% duty cycle.
Device: Pulsed Ultrasound Therapy
Ultrasound therapy is applied in the pulsed mode.
CMAP distal latency
msecond
Time frame: Immediately after application
CMAP amplitude
mV
Time frame: Immediately after application
CMAP duration
msecond
Time frame: Immediately after application
Nerve conduction study
m/sec.
Time frame: Immediately after application
Plan to share: Yes — There is a plan to make IPD and related data dictionaries available.
Supporting information: Study protocol, Clinical study report
Time frame: Within six months of termination of the current study.
Access criteria: IPD sharing will be done after publication of the study results
No publications or documents are linked to this record.
This study is status unknown, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.